Skip to main content
Log in

Alemtuzumab

Graves disease: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Thakar R, et al. Response to Letter to the Editor: "alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features". Journal of Clinical Endocrinology and Metabolism 104: 3626-3627, No. 9, Sep 2019. Available from: URL: http://doi.org/10.1210/jc.2018-02593 - UnitedKingdom

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1768, 30 (2019). https://doi.org/10.1007/s40278-019-66715-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-66715-9

Navigation